$OGEN

Oragenics Inc

  • NYSE MKT LLC
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.3557 ▲4.189%

Extented Hours

VOLUME

13,750

DAY RANGE

- 0.3542

52 WEEK

0.2184 - 1.15

Join Discuss about OGEN with like-minded investors

profile
@maletone #StockTraders.NET
recently

hope $OGEn can get to 1.20s to short

149 Replies 11 👍 10 🔥

profile
@Math #StockTraders.NET
recently

$XELA $OGEN $XBIO $TYME $OBSV $EYEG $TSLA

81 Replies 8 👍 6 🔥

profile
@NFrenchTrader #StockTraders.NET
recently

$OGEN on way back down. vey nice

91 Replies 10 👍 7 🔥

profile
@NFrenchTrader #StockTraders.NET
recently

$OGEN flying pm

103 Replies 11 👍 15 🔥

profile
@Armm5 #StockTraders.NET
recently

$OGEN chat room

150 Replies 10 👍 6 🔥

profile
@rickyanalog #StockTraders.NET
recently

also will lean inot $OGEN around 2.50

104 Replies 15 👍 13 🔥

Key Metrics

Market Cap

39.74 M

Beta

0

Avg. Volume

330.22 K

Shares Outstanding

116.39 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-12

Next Dividend Date

Company Information

Oragenics, Inc. is focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic and the further development of effective treatments for novel antibiotics against infectious disease. The Company is dedicated to the development and commercialization of a vaccine candidate providing specific immunity from novel coronavirus. The Terra CoV-2 immunization leverages coronavirus spike protein research conducted by the National Institute of Health. In addition, Oragenics has an exclusive worldwide channel collaboration with ILH Holdings, Inc. (n/k/a Eleszto Genetika, Inc.), relating to the development of novel lantibiotics.

Website:

HQ: 4902 Eisenhower Blvd Ste 125 Tampa, 33634-6342 Florida

Related News